With the increase in the number of long-term cancer survivors worldwide, there is a growing concern about the risk of secondary cancers induced by radiotherapy. Epigenetic modifications of genes associated with carcinogenesis are attractive targets for the prevention of cancer owing to their reversible nature. To identify genes with possible changes in functionally relevant DNA methylation patterns in mammary carcinomas induced by radiation exposure, we performed microarray-based global DNA methylation and expression profiling in c-ray-induced rat mammary carcinomas and normal mammary glands. The gene expression profiling identified dysregulation of developmentally related genes, including the downstream targets of polycomb repressive complex 2 (PRC2) and overexpression of enhancer of zeste homolog 2, a component of PRC2, in the carcinomas. By integrating expression and DNA methylation profiles, we identified ten hypermethylated and three hypomethylated genes that possibly act as tumor-suppressor genes and oncogenes dysregulated by aberrant DNA methylation; half of these genes encode developmental transcription factors. Bisulfite sequencing and quantitative PCR confirmed the dysregulation of the polycomb-regulated developmentally related transcription-factor genes Dmrt2, Hoxa7, Foxb1, Sox17, Lhx8, Gata3 and Runx1. Silencing of Hoxa7 was further verified by immunohistochemistry. These results suggest that, in radiation-induced mammary gland carcinomas, PRC2-mediated aberrant DNA methylation leads to dysregulation of developmentally related transcriptionfactor genes. Our findings provide clues to molecular mechanisms linking epigenetic regulation and radiation-induced breast carcinogenesis and underscore the potential of such epigenetic mechanisms as targets for cancer prevention.
Introduction
Radiotherapy is often an integral part of cancer treatment as >50% of cancer patients in developed countries receive radiotherapy during their course of therapy. 1 However, the increase in the number of long-term cancer survivors, resulting from advances in cancer treatment, has raised concerns about the risk of radiation-induced secondary cancers. 2, 3 Thus, new strategies must be developed to minimize the occurrence of radiation-induced cancers. 4 In this regard, the epigenetic changes, such as DNA methylation, that occur during carcinogenesis are particularly attractive targets because they are potentially reversible. [5] [6] [7] It is now generally recognized that methylation of genomic DNA constitutes the major type of epigenetic modification and that changes in DNA methylation patterns critically affect carcinogenesis by influencing gene expression. 8 Hypermethylation of promoter CpG islands is associated with transcriptional silencing of tumor-suppressor genes in cancer cells and is recognized as an alternate means of inducing mutations/deletions that help to promote and/or maintain a cancerous state. 9, 10 Conversely, DNA hypomethylation of transposable elements and imprinted gene results in their aberrant activation, and global DNA hypomethylation can induce genomic instability. [11] [12] [13] [14] [15] Several reports have demonstrated that exposure to ionizing radiation affects DNA methylation patterns. In rodent models, for example, exposure to ionizing radiation-induced effects on global DNA hypomethylation that were dosedependent, and sex-, and tissue-specific. 16, 17 Consistent with the results showing hypomethylation, reduced expression of DNA methyl-transferases 1, 3a and 3b and of methyl CpG binding protein 2 was observed in irradiated tissues, suggesting that DNA hypomethylation induced by radiation exposure may result in genomic instability. Notably, the DNA methylation inhibitor, zebularine, inhibited ionizing radiation-induced development of murine lymphoma, 18 a finding emphasizing the importance of increased DNA methylation in radiationinduced carcinogenesis.
The mammary gland is the most sensitive organ to radiation-induced carcinogenesis. [19] [20] [21] [22] However, the molecular mechanisms underlying radiation-induced breast cancer have yet to be well characterized because breast cancer in humans occurs as a result of the combined effects of radiation and other factors including age, family history and lifestyle. 23 Epigenetic changes in cancer are influenced by various factors including cancer etiology; [24] [25] [26] however, only a limited amount of information is available on the epigenetic feature(s) of radiation-induced cancers. Animal models are useful when studying the contribution of a single factor related to carcinogenesis. A rat model for mammary carcinogenesis is widely used to study breast cancer risk and mechanisms of breast carcinogenesis because tumors of the rat mammary gland and human breast are comparable in many aspects, including their hormone dependence and pathological processes of malignant transformation. 27 Female SpragueDawley (SD) rats are highly susceptible to mammary carcinogenesis. 28 In a previous study involving genomic methylation in SD rats, we showed that the majority of genes with tumorspecific hypermethylation are developmentally related transcription-factor genes. 29 However, no obvious candidate signaling pathway was found based on the relationships between the hypermethylated and differentially expressed genes in the radiation-induced mammary carcinomas. In our recent study using F1 hybrid of SD rats and mammary cancer-resistant Copenhagen (COP) rats, abnormal expression of genes involved in the PI3K/Akt pathway, a frequently dysregulated pathway in human breast cancer, was observed in radiation-induced rat mammary carcinomas, although the number of cancer-related mutations was small, suggesting the involvement of epigenetic alterations. 30 For the study reported herein, to identify genes with potential changes in functionally relevant DNA methylations related to radiation-induced mammary carcinomas, we conducted genome-wide analyses of the changes in DNA methylation and gene expression in rat mammary carcinomas induced by radiation exposure using the F1 hybrid SD-COP model. Our study indicated that polycomb repressive complex 2 (PRC2)-mediated DNA methylation of developmentally related transcription-factor genes is critical for dysregulation of developmentally related genes in radiationinduced mammary carcinogenesis. We also identified ten hypermethylated and three hypomethylated genes, including developmentally related transcription-factor genes, as tumorsuppressor genes and oncogenes that are dysregulated by aberrant DNA methylation. These findings suggest a link between developmental dysregulation through aberrant DNA methylation and radiation-induced breast carcinogenesis.
Materials and Methods

Tumor samples
Animal experiments were approved by the Institutional Animal Care and Use Committee of the National Institute of Radiological Sciences. F1 hybrid rats were generated by crossing mammary cancer-susceptible SD and -resistant COP rats. Female SD (Jcl:SD) rats were purchased from CLEA Japan, Inc. (Tokyo, Japan). Male and female COP (COP/Hsd) rats were obtained from Harlan Sprague Dawley, Inc. (Madison, WI) and were maintained by brother-sister mating. The breeding of the (SD 3 COP) F1 hybrid rats was performed in a facility at the National Institute of Radiological Sciences. They were maintained under specific pathogen-free conditions controlled temperature (23 6 18C), humidity (45 6 5%) and a 12-hr light/12-hr dark cycle. Rats were fed a standard CE-2 diet (CLEA, Japan) and sterile water ad libitum. When aged 7 weeks, female F1 rats (n 5 29) were exposed to whole-body c-radiation (a total of 4 Gy) using a 137 Cs source (Gammacell; Nordion International, Ottawa, Canada) at a dose rate of 0.5 Gy/min. The treated rats were observed daily and palpated weekly beginning 2 weeks after irradiation to identify mammary tumors. Animals that had generally deteriorated during the observation period, defined as body mass loss and severe anemia owing to tumor burden, were euthanized and any mammary tumors collected, as were tumors discovered post-mortem in rats that were found dead. Mammary tumors and normal glands both from the same tumorbearing rats were frozen in liquid nitrogen and stored at 2808C. Histologically diagnosed adenocarcinomas were What's new? Development of a secondary cancer after radiotherapy is of growing concern for long-term cancer survivors. Here the authors examined epigenetic marks in radiation-induced rat mammary carcinomas. They found polycomb repressive complex 2-mediated aberrant DNA methylation of developmentally relevant transcription factor-encoding genes and a consequent dysregulation of downstream gene targets during carcinogenesis, underscoring the potential of epigenetics in secondary cancer prevention.
retained for further study; immunotyping indicated that the majority of the carcinomas were of the luminal subtype. 30 
DNA methylation profiling
Methylated DNA was captured using Methylminer Methylated DNA Enrichment kit reagents (Invitrogen, Tokyo, Japan). We used 1 lg of sonicated DNA (200-to 600-bp fragments). Methylated DNA was eluted from the bead complex with 2 M NaCl and purified by ethanol precipitation. DNAs enriched in methyl-binding domain-enriched and input DNAs (1 lg) were labeled with Cy5 and Cy3 dye, respectively, and co-hybridized to a rat CpG island oligonucleotide microarray (Agilent Technologies, Tokyo, Japan) that contained 93,024 probes corresponding to 13,026 CpG islands associated with 8,281 genes. The microarray slide was scanned with an Agilent G2565CA microarray scanner, and the scanned data were processed using Agilent Genomic Workbench Software 6.5. The microarray data have been deposited in the Gene Expression Omnibus database (www. ncbi.nlm.nih.gov/geo) under accession number GSE96565.
Analysis of DNA methylation data
DNA methylation profiling data were analyzed with Genomic Workbench software 6.5 as described. 29 Briefly, with the software algorithm, the degree of enrichment (or non-enrichment) by the methylated DNA enrichment step was compared to the overall distribution of enrichment for probes of the same melting temperature to calculate the probability that the CpG island represented by each probe was methylated or unmethylated. This was ultimately expressed as the log of the odds ratio (LogOdds), probability of methylated/probability of unmethylated, such that a LogOdds score of 0 is equally likely to be methylated/unmethylated, whereas large absolute values are increasingly likely to be methylated or unmethylated (positive values or negative values, respectively). To identify significant differences in DNA methylation between the carcinomas and normal tissues, independent samples t-tests for the mean of the LogOdds between the two groups (p < 0.05) were performed for each probe, with a >3-fold mean LogOdds difference between the groups, and probes showing LogOdds scores >0 or <0 for more than half of the carcinomas were extracted for hypermethylated or unmethylated probes, respectively. For the identification of the hypomethylated genomic regions in the carcinomas, at least three consecutive probes meeting the above criteria were extracted.
Gene expression profiling
Total RNA was extracted, labeled with cyanine 3-CTP, and hybridized to a rat oligonucleotide microarray (SurePrint G3 Rat GE microarray; Agilent Technologies) as described. 31 The raw microarray data were normalized and analyzed using GeneSpring GX v. 11.5.1 (Agilent Technologies) and the PANTHER classification system (http://www.pantherdb.org/). Expression data for selected genes were visualized using TIGR MultiExperiment Viewer software (http://www.tm4. org/mev.html). Microarray data have been deposited in the Gene Expression Omnibus database under accession number GSE96085.
Quantitative real-time PCR (qPCR)
First-strand cDNA was synthesized from total RNA as described. 31 qPCR was performed on an Mx3000P real-time PCR system (Stratagene, La Jolla, CA). Primer sequence information is available in Supporting Information Table S1 .
Bisulfite sequencing
Genomic DNA (200 ng) and BisulFlash DNA Modification kit reagents (EpiGentek, Brooklyn, NY) were used for bisulfite conversion. Briefly, DNA samples were treated for 20 min at 958C with sodium bisulfite, desalted, desulfonated and eluted with elution buffer from the kit. The modified DNA (1-2 mL) was used for bisulfite PCR in conjunction with EpiTaq Hot-Start DNA polymerase (Takara Bio, Otsu, Japan). The bisulfite-sequencing primers were designed using the Methprimer online tool (http://www.urogene.org/methprimer/index.html). The primer sequences are given in Supporting Information Table S1 . Each PCR product was cloned into vector pCR2.1 using TOPO TA Cloning kit reagents (Invitrogen), and sequences were verified by DNA sequencing. The bisulfite-sequencing data were analyzed using QUMA (http://quma.cdb.riken.jp/).
Immunohistochemistry and scoring
Formalin-fixed, paraffin-embedded tissues were cut into 3-lm sections, dewaxed with xylene, and rehydrated sequentially in a series of graduated ethanol solutions. Antigen retrieval was performed with by a microwave treatment at 988C in 10 mM citrate (pH 6.0) for 20 min for Hoxa7 and with an autoclave treatment at 1208C for 20 min for Ezh2. Endogenous peroxidase activity was quenched with 0.3% (v/ v) hydrogen peroxide. Sections were blocked in 10% (v/v) goat serum for 30 min at room temperature and incubated overnight at 48C with primary antibodies against Hoxa7, Ezh2 and c-Myc (Aviva Systems Biology, San Diego, CA, catalog number OAAB10779, dilution 1:300; Cell Signaling Technology, Beverly, MA, catalog number 5246, dilution 1:100 and Abcam, Tokyo, Japan, catalog number ab32072, dilution 1:30, respectively). A secondary antibody against rabbit IgG and avidin-biotin (ABC) reagent were then applied (Vectastain ABC Elite kit, Vector Laboratories, Burlingame, CA). The sections were visualized with diaminobenzidine and counterstained with hematoxylin. Stained slides were analyzed using Tissue Studio software (Definiens, Munich, Germany). The immunohistochemistry score was determined by multiplying the staining intensity (0-3) by the percentage of positive nuclei. 32 
Statistical analysis
Statistical analysis was carried out with GraphPad StatMate software v. 3.0 (ATMS, Tokyo, Japan). Comparison between Cancer Genetics and Epigenetics Daino et al. two groups was done using the two-tailed Student's t-test. A p-values < 0.05 was considered to be statistically significant.
Results
Profiling of DNA methylation in radiation-induced rat mammary carcinomas
To identify changes in global DNA methylation in mammary carcinomas induced by ionizing radiation, we compared their CpG island methylation profiles with those of normal mammary glands using rat CpG island microarrays that contain probes corresponding to 13,026 CpG islands associated with 8,281 genes. A total of 1,175 differentially methylated CpG islands were identified, with 769 being hypermethylated and 406 being hypomethylated in the carcinomas compared to the same regions in the normal tissues (Figs. 1a and 1b) . Gene annotation revealed that, for the hypermethylated regions, 30% mapped to a gene promoter and 28% to a gene (Fig. 1c) , whereas for the hypomethylated regions, we noted the reverse tendency, i.e., 13% and 56%, respectively (Fig. 1d) , indicating independent roles for hypermethylation and hypomethylation in gene regulation in the carcinomas.
Profiling of gene expression in radiation-induced rat mammary carcinomas
To identify differentially expressed genes in mammary carcinomas and normal mammary glands, we performed global gene expression analyses using a microarray that contained a probe set for 30,003 rat transcripts. As shown in Figure 2a , we identified 1,153 transcripts that were differentially expressed. We found that 265 transcripts were upregulated and 888 transcripts were downregulated in the carcinomas compared to normal tissues (3-fold change).
We next classified the functions of the differentially expressed 1,153 transcripts using the gene ontology (GO) database. As shown in Figure 2b , the categories included genes involved in cellular processes (20.2%), metabolic processes (19.3%), developmental processes (9.9%), the immune system (9.4%), localization (8.2%), responses to stimuli (8.0%), biological regulation (7.6%), multicellular organismal processes (5.8%), adhesion (4.5%), cellular component organization (2.6%), apoptosis (2.3%) and reproduction (2.3%). Many of the differentially expressed genes in the carcinomas were found to be involved in the immune response, ligand-mediated signaling, developmental processes and cell communication and cell adhesion as evidenced by their enrichment in GO terms (Fig. 2c) . We found that the majority of the proteins encoded by the differentially express genes involved in the immune response, ligand-mediated signaling and cell communication were chemokines, interleukins and cell surface antigens, and many of their genes were downregulated in the carcinomas, suggesting decreased immunogenic fitness for the cancer cells, which would affect their survival 
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Daino et al. Information Tables S2, S3 and S5). The dysregulation of genes involved in developmental processes in the carcinomas may reflect perturbation of normal developmental programs of mammary glands. Interestingly, many developmentally related transcription-factor genes were downregulated in the carcinomas (Supporting Information Table S4 ). This may cause dedifferentiation of the cancer cells. Downregulation of many cell adhesion genes was also found in the carcinomas, and this may promote migration and invasion of cancer cells (Supporting Information Table S6 ).
(Supporting
To further analyze the microarray data, we used gene set enrichment analysis to identify groups of functionally related genes according to their degree of global up-or downregulation in the carcinomas compared to normal tissues. A total of 269 gene sets were identified by the enrichment analysis as significantly enriched in up-or downregulated genes in the carcinomas (Supporting Information Table S7 ). Included in these sets were genes dysregulated in a number of human cancers, genes involved in several transcriptional networks, and genes involved in differentiation and developmental processes. Genes related to human breast cancer were up-or downregulated in the carcinomas (Supporting Information Table S7a ). Upregulation of Rb/E2F and p53 regulatory pathways in the carcinomas was also indicated (Supporting Information Table S7b) .
Strikingly, this analysis also uncovered an enrichment in PRC2-related gene sets, including the target genes of PRC2-regulated developmentally related transcription factors 33 and the genes marked by PRC2-mediated histone H3 methylation 34 (Supporting Information Tables S7b and S7c ). In line with the dysregulation of the PRC2 pathway, gene sets related to stem cells and immature mammary gland cells were enriched in the carcinomas (Supporting Information Table  S7c ). These findings indicated the pivotal role(s) of changes in PRC2-mediated gene expression in the carcinomas, so we then focused further on the PRC2 pathway. Plots of the strongly enriched gene sets of PRC2 and Ezh2 targets are shown in Figures 3a and 3b , respectively.
The gene expression microarray data revealed a statistically significant upregulation of Ezh2 (1.7-fold), encoding a catalytic component of PRC2, in the carcinomas compared to normal tissues, although no significant change in the expression of the other genes (Suz12 and Eed) encoding core subunits of PRC2 was observed (data not shown). The qPCR results also revealed a carcinoma-specific and statistically significant increase in the expression of Ezh2 mRNA (Fig. 3c) . We also found a statistically significant increase in the expression of Ezh2 in the carcinomas as compared to normal tissues (Figs. 3d-f) . c-Myc, E2F and HIF-1 are known transcriptional activators of Ezh2. 35 Our gene expression microarray data indicated that, although statistically nonsignificant, expression of c-Myc in the carcinomas appeared to be somewhat increased compared to that in the normal tissues; conversely, no observable, even if not significant, change in expression of the E2F family and HIF-1 genes was observed.
No clear correlation between Ezh2 and c-Myc expression at their mRNA and protein levels was observed by qPCR or immunohistochemistry (Supporting Information Fig. S1 ). However, several carcinomas (36.4%, 4 of 11) exhibited increased expression of Ezh2 and c-Myc, suggesting the involvement of c-Myc activity in the overexpression of Ezh2 in a subset of the carcinomas.
Integrated analysis of gene expression and DNA methylation profiles
To identify genes with potential changes in relevant DNA methylation in the mammary carcinomas, we integrated their gene expression and DNA methylation profiles as follows. We identified 13 genes with DNA hypermethylation and decreased expression or DNA hypomethylation and increased expression (expression change of 2-fold) in the carcinomas compared to the normal tissues (Table 1) . Notably, 70.0% (9 of 13) of these genes are targeted by the PRC2. 36, 37 Moreover, the majority (7 of 9) of the PRC2-targeted genes are developmentally related transcription-factor genes, i.e., Dmrt2, Hoxa7, Lhx8, Foxb1, Sox17, Gata3 and Runx1, which suggests that expression of development-associated PRC2-target genes was dysregulated through an abnormal DNA methylationmediated control of their master transcriptional regulator(s); in turn, the subsequent alterations likely induced the developmental abnormalities during mammary carcinogenesis.
Dysregulation of polycomb-regulated developmentally related transcription-factor genes in radiation-induced rat mammary carcinomas Table 1 lists the candidate tumor-suppressor genes and oncogenes dysregulated by aberrant DNA methylation in the carcinomas. Of these, the polycomb-regulated developmentally related transcription-factor genes Dmrt2, Hoxa7, Foxb1, Sox17, Lhx8, Gata3 and Runx1 were assessed for DNA methylation and mRNA expression by bisulfite sequencing and qPCR, respectively, to confirm reproducibility of the microarray results. In accordance with the microarray data, we found that the Dmrt2, Hoxa7, Foxb1, Sox17 and Lhx8 were hypermethylated and that their expression was downregulated in the carcinomas compared to normal tissues (Figs. 4 and 5) . Hypomethylation of the Gata3 and Runx1 and upregulation of both these genes in the carcinomas compared to normal tissues were also confirmed (Fig. 6 ). To further evaluate the silencing of greatly downregulated genes Dmrt2 and Hoxa7 in the carcinomas at the protein level and their locations, we subjected tissue sections to immunohistochemistry. Although the commercially available antibody against rat Dmrt2 did not work in this assay, we found, as we had in the mRNA expression assays, decreased expression of Hoxa7 in the luminal epithelium of carcinomas compared to the levels of the same protein in normal mammary epithelium (Figs. 4i-k) .
Discussion
The mammary gland is the most sensitive organ to radiationinduced carcinogenesis, such that concern about the risk of induction of breast cancer after radiotherapy of other nearby organs has increased in recent years. Unlike genetic changes, epigenetic changes associated with cancer are potentially reversible; therefore, identifying and characterizing the epigenetic changes that are relevant to carcinogenesis is an important research field. For the study reported herein, to identify genes with potentially functionally relevant changes in DNA methylation associated with radiation-induced mammary carcinomas in rats, we performed microarray-based global DNA methylation and expression profiling for these carcinomas and normal mammary glands. We observed dysregulation of developmentally related genes, including downstream targets of PRC2, and overexpression of Ezh2, a catalytic component of the PRC2, in the carcinomas. Involvement of PRC2-mediated transcriptional dysregulation in the carcinomas was also supported by the enrichment of PRC2-related gene sets, e.g., the target genes of PRC2-regulated developmentally related transcription factors and the genes marked by PRC2-mediated histone H3 methylation, as shown by the Figure 3 . Dysregulation of the genes targeted by PRC2 in radiation-induced rat mammary carcinomas. Gene set enrichment analysis of gene sets up-or downregulated in carcinomas compared to those in normal mammary tissues. Enrichment plots and corresponding heat maps for the target gene sets of PRC2 (a) and EZH2 (b) (p < 0.05 and FDR q < 0.25). Gene sets from the C2 collection of the Molecular Signatures Database were tested for enrichment in the list of genes ranked by expression changes in the carcinomas versus normal tissues. NES, normalized enrichment score; FDR, false discovery rate. (c) Real-time qPCR showing relative expression of Ezh2 mRNA in normal mammary glands (n 5 11) and mammary carcinomas (n 5 11). Representative immunohistochemical staining for Ezh2 in carcinoma (d) and normal tissue (e) sections. Scale bars, 5 mm and 100 lm, respectively. The areas indicated by the boxes are enlarged in the insets. Scale bars, 50 lm. (f) Relative expression of Ezh2 according to immunohistochemistry (IHC) scores in normal mammary glands (n 5 21) and carcinomas (n 5 21). Significant differences between the normal mammary glands and carcinomas were characterized using the two-tailed Student's ttest. **p < 0.01.
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gene set enrichment study. A total of ten hypermethylated and three hypomethylated genes were identified as candidate tumor-suppressor genes and oncogenes dysregulated by aberrant DNA methylation, and half of these were developmentally related transcription-factor genes. Among these, we confirmed the carcinoma-specific DNA hypermethylation and downregulation of Dmrt2, Hoxa7, Foxb1, Sox17 and Lhx8. We also observed hypomethylation of Gata3 and Runx1 genes and upregulation of both genes in the carcinomas compared to normal tissues. In addition, because the DNA methylation status of the identified genomic regions was recurrently different in the carcinomas than in normal tissues, aberrant DNA methylation and dysregulation of the identified genes may be an early event in the development of radiation-induced mammary cancer. These data should provide clues to molecular mechanisms underlying radiationinduced mammary carcinogenesis and underscore the potential of such reversible epigenetic mechanisms as targets of cancer prevention. The PRC2-mediated transcriptional regulation of gene expression is an important mechanism that operates during normal development, and dysregulation of this system often occurs in cancer. 33, 38 By using a combinatorial approach to investigate radiation-induced rat mammary carcinomas, we found a correlation between aberrant DNA methylation and dysregulation of PRC2-regulated transcription-factor gene expression. The genes identified with both alterations include Dmrt2, Hoxa7, Foxb1, Sox17, Lhx8, Gata3 and Runx1. Interestingly, Hoxa7, Foxb1, Gata3 and Runx1 are expressed or required during normal development of the mammary gland. [39] [40] [41] [42] Hypermethylation of Hoxa7 and Sox17 has been observed in several human cancers, including breast cancer. [43] [44] [45] [46] [47] [48] Moreover, downregulation of Dmrt2 and upregulation of Gata3 and Runx1 in human breast carcinoma has been reported. [49] [50] [51] [52] These reports, together with the current findings, suggest the involvement of PRC2-mediated DNA hypermethylation of developmentally related transcriptionfactor genes in radiation-induced mammary carcinomas, which likely leads to dysregulation of their downstream genes and subsequent developmental abnormalities during carcinogenesis. Indeed, the expression profiling in our study indicated dysregulation of a number of developmentally related genes. These results suggest that the rat radiation-induced mammary carcinoma model can be used to test the efficacy of agents such as bioactive dietary components and chemical compounds that target epigenetic changes to develop strategies to minimize the incidence of radiation-associated breast cancer. 6, 7 From clinical perspective, the use of inhibitors of DNA methylation, e.g., azacytidine and decitabine, has been proposed as a therapeutic strategy for radiation-induced breast cancers. 53, 54 In addition, our data suggest the clinical potential of PRC2-targetted cancer treatment by EZH2 inhibitors, e.g., 3-deazaneplanocin A. 55, 56 Treatment with such drugs may benefit high-risk groups, e.g., survivors of a primary cancer who had received a high radiation dose to normal tissues during childhood. Conversely, less invasive, bioactive dietary components might be more relevant to cancer prevention in low-risk groups. In this regard, several (k) Relative expression of Hoxa7 according to immunohistochemistry (IHC) scores in normal mammary glands (n 5 21) and carcinomas (n 5 21). Significant differences between the normal mammary glands and the carcinomas were characterized using the two-tailed Student's t-test. **p < 0.01, ***p < 0.001.
bioactive food components, e.g., (2)-epigallocatechin-3-gallate and omega-3 fatty acids, have been shown to reduce EZH2 expression and postulated as potential chemopreventive agents. 7, 57, 58 Interestingly, exposure to ionizing radiation induces persistent expression of genes encoding transcriptional activators of Ezh2, c-Myc, E2F and HIF-1a in mammary gland of mice, 35, 59, 60 suggesting involvement of these activators in the overexpression of Ezh2 mRNA, as observed in our study. We found that in a subset of mammary carcinomas (36.4%, 4 of 11) expression of Ezh2 and c-Myc increased, which suggested involvement of cMyc. The identification of upstream regulators of Ezh2 expression in radiation-induced mammary carcinomas may also lead to effective strategies for cancer prevention.
In conclusion, we identified tumor-suppressor genes and oncogenes that are dysregulated by aberrant DNA Figure 5 . DNA methylation of the Foxb1, Sox17 and Lhx8 and expression of those genes in radiation-induced rat mammary carcinomas. Schematics of the Foxb1 (a), Sox17 (e) and Lhx8 (i) promoters. CpG islands are presented as vertical bars; the arrow in (a) indicates the transcription initiation site. The gray horizontal bar in each panel indicates the region analyzed. Bisulfite sequencing revealed methylation patterns of the Foxb1 (b), Sox17 (f) and Lhx8 (j) in normal rat mammary glands (top panels) and mammary carcinomas (middle and bottom panels). Open circles: unmethylated CpG islands; closed circles: methylated CpG islands. DNA methylation levels for Foxb1 (c), Sox17 (g) and Lhx8 (k) in normal rat mammary glands (n 5 2) and mammary carcinoma samples (n 5 6) are presented as the percentage of methylated CpG islands found for all CpG islands in each sample. DNA methylation levels in normal mammary glands from rats 7 weeks of age (n 5 2) are also shown. qPCR showing the relative expression of Foxb1 (d), Sox17 (h) and Lhx8 (l) in normal rat mammary glands (n 5 10) and mammary carcinomas (n 5 10). methylation in radiation-induced rat mammary cancer. Notably, the majority of these genes encode developmentally associated transcription factors, which are known to be regulated by PRC2, suggesting the existence of a link between developmental dysregulation through aberrant DNA methylation and radiation-induced mammary carcinogenesis. Figure 6 . DNA methylation of Gata3 and Runx1 and expression of those genes in radiation-induced rat mammary carcinomas. Schematics of the Gata3 (a) and Runx1 (e) promoters. CpG islands are presented as vertical bars; the arrow in panel a indicates the transcription initiation site of Gata3. The gray horizontal bar in each panel indicates the region analyzed. Bisulfite sequencing revealed methylation patterns of the Gata3 and Runx1 in normal rat mammary glands and mammary carcinomas. Representative bisulfite sequencing results for the Gata3 (b) and Runx1 (f) in normal mammary glands (top panels) and in two carcinomas (middle and bottom panels). Open circles: unmethylated CpG islands; closed circles: methylated CpG islands. DNA methylation levels of Gata3 (c) and Runx1 (g) in normal rat mammary glands (n 5 2) and mammary carcinomas (n 5 6) are presented as the percentage of methylated CpG islands found for all CpG islands in each sample. DNA methylation levels in normal mammary glands from rats 7 weeks of age (n 5 2) are also shown. qPCR showing the relative expression of Gata3 (d) and Runx1 (h) in normal rat mammary glands (n 5 11) and in mammary carcinomas (n 5 11). Significant differences between the types of tissues were determined using the two-tailed Student's t-test. *p < 0.05.
